2. 您的位置
3. 首页
4. 会议论文
5. Effect of reducing the dose of biological agents on future subclinical inflammation as evaluated by

Effect of reducing the dose of biological agents on future subclinical inflammation as evaluated by

来源 :2016年第18届亚太风湿病协会联盟大会(APLAP) | 被引量 : 0次 | 上传用户：liushanxue

【作 者】

：

Y.C.Chen 

【机 构】

：

Kaohsiung Chang Gung Memorial Hospital,Rheumatology,Kaohsiung City,Taiwan

【出 处】

：

2016年第18届亚太风湿病协会联盟大会(APLAP)

【发表日期】

：

2016年3期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

The efficacy of lentiviral-mediated RNA interference targetting TNF-α in vitro and in vivo

会议

Anemia improvement of infliximab in patients with rheumatoid arthritis and ankylosing spondylosis.

会议

Restarting biologics in patients who developed tuberculosis under anti-TNF alpha treatment

会议

Strategic Usage in Rheumatoid arthritis with Infliximab as Switched Biologics

会议

Value of head-to-head studies in RA to improve management and treatment decisions in clinical practi

会议

Pathology and therapy of renal involvement in ankylosing spondylitis

会议

Clinical and patient-reported benefits of certolizumab pegol treatment in MTX-na?ve,early RA patient

会议

Chronic disease management mode is benefit for the rheumatoid arthritis patients treated by the biol

会议

Maintenance of LDA and remission with etanercept-DMARD combination treatment compared with DMARDs al

会议

Drug survival of biologic agents in rheumatoid arthritis using 10 years of nationwide data in Korea:

会议